摘要
目的探讨胸痛救治单元建设对转运实施急诊介入治疗的急性ST段抬高型心肌梗死(STEMI)患者救治效率及预后的影响。方法通过回顾性研究方法,选取绵阳市17家通过验收的胸痛救治单元在建设期间(2021年4月至2021年12月)收治的71例行急诊经皮冠状动脉介入治疗(PCI)的STEMI患者为胸痛救治单元组,以及去年同期(2020年4月至2020年12月)收治的61例急诊PCI患者为非胸痛救治单元组。比较两组患者的首份心电图完成时间、心电图确诊时间、双联抗血小板药物给药时间、转入-转出时间和院内死亡率。结果胸痛救治单元组的首份心电图完成时间[(4.51±2.87)min比(29.41±10.23)min]、心电图确诊时间[(3.47±1.15)min比(10.25±4.55)min]、双联抗血小板药物给药时间[(4.84±2.11)min比(22.33±7.99)min]、转入-转出时间[(26.87±9.62)min比(102.27±21.23)min]和院内死亡率(4.23%比11.48%)均显著低于非胸痛救治单元组,差异均有统计学意义(均P<0.001)。结论胸痛救治单元建设可以缩短转运实施急诊介入治疗STEMI患者的救治时间,降低死亡率。
Objective Objective To explore the eff ect of the construction of chest pain unit on the treatment efficiency and prognosis of patients with acute ST-segment elevation myocardial infarction(STEMI)undergoing emergency interventional therapy.Methods Through retrospective research methods,this study selected 71 patients with STEMI treated by emergency percutaneous coronary intervention in 17 accepted chest pain treatment units in Mianyang during the construction period(April 2021 to December 2021),and 61 patients treated in the same period a year before(April 2020 to December 2020),which were divided into chest pain unit group and non-chest pain unit group.The first ECG completion time,ECG diagnosis time,administration time of dual antiplatelet drugs,door in and door out time and in-hospital mortality were compared between the two groups.Results The first ECG completion time[(4.51±2.87)min vs.(29.41±10.23)min],ECG diagnosis time[(3.47±1.15)min vs.(10.25±4.55)min],administration time of dual antiplatelet drugs[(4.84±2.11)min vs.(22.33±7.99)min],door in and door out time[(26.87±9.62)min vs.(102.27±21.23)min]and in-hospital mortality(4.23%vs.11.48%)in the chest pain treatment unit group were signifi cantly lower than those in the non-chest pain treatment unit group.The diff erence was statistically signifi cant(all P<0.001).Conclusions The construction of chest pain treatment unit can shorten the treatment time of patients with STEMI undergoing emergency interventional therapy and reduce the mortality.
作者
叶廷巧
蒋涛
罗彩东
YE Ting-qiao;JIANG Tao;LUO Cai-dong(Mianyang Central Hospital,School of Medicine,University of Electronic Science and Technology of China,Mianyang 621000,China)
出处
《中国介入心脏病学杂志》
2022年第7期545-548,共4页
Chinese Journal of Interventional Cardiology
基金
绵阳市卫健委2020年科研课题补助项目(202010)
四川医院管理和发展研究中心重点项目(SCYG2021-01)。
作者简介
通信作者:蒋涛,Email:2155305216@qq.com。
